In Vitro Direct Reprogramming of Mouse and Human Astrocytes to Induced Neurons
- PMID: 32474866
- DOI: 10.1007/978-1-0716-0655-1_4
In Vitro Direct Reprogramming of Mouse and Human Astrocytes to Induced Neurons
Abstract
Direct neuronal reprogramming, rewiring the epigenetic and transcriptional network of a differentiated cell type to neuron, apart from being a very promising approach for the treatment of brain injury and neurodegeneration, also offers a prime opportunity to investigate the molecular underpinnings of neuronal cell fate determination, as the precise molecular mechanisms that establish neuronal fate and diversity at the transcriptional and epigenetic level are incompletely understood. Recent studies from a number of groups, including ours, have shown that astrocytes can be directly reprogrammed into functional neurons in vitro and in vivo following ectopic overexpression of combinations of transcription factors, neurogenic proteins, miRNAs, and small chemical molecules.In this chapter we describe the protocols for in vitro converting primary cortical astrocytes of mouse and human origin to induced neurons, through forced expression of two neurogenic molecules, either each one alone or in combination: the master regulatory bHLH proneural transcription factor NEUROGENIN-2 (NEUROG2) and the neurogenic protein CEND1. Forced expression of each one of the two neurogenic proteins in primary astrocytes via retroviral gene transfer results in their direct conversion to subtype-specific induced neurons, while simultaneous coexpression of both molecules drives them predominantly toward acquisition of a neural precursor cell (NPC) state. Although mouse and human astrocytes exhibit differences in their reprogramming rate and particular characteristics, they can both get efficiently in vitro transdifferentiated to NPCs and induced neurons upon NEUROG2 or/and CEND1 forced expression using the reprogramming protocols described in the chapter, presenting valuable cellular platforms for mechanistic studies and in vivo applications to restore neurodegeneration.
Keywords: Astrocytes; Cend1; Induced neurons; Neural progenitor cells; Neurogenin2; Reprogramming; Transdifferentiation.
Similar articles
-
CEND1 and NEUROGENIN2 Reprogram Mouse Astrocytes and Embryonic Fibroblasts to Induced Neural Precursors and Differentiated Neurons.Stem Cell Reports. 2015 Sep 8;5(3):405-18. doi: 10.1016/j.stemcr.2015.07.012. Epub 2015 Aug 28. Stem Cell Reports. 2015. PMID: 26321141 Free PMC article.
-
In Vitro and In Vivo Direct Reprogramming of Astrocytes to Induced-Neurons.Methods Mol Biol. 2025;2899:183-198. doi: 10.1007/978-1-0716-4386-0_13. Methods Mol Biol. 2025. PMID: 40067625
-
Bcl-2-Assisted Reprogramming of Mouse Astrocytes and Human Fibroblasts into Induced Neurons.Methods Mol Biol. 2021;2352:57-71. doi: 10.1007/978-1-0716-1601-7_5. Methods Mol Biol. 2021. PMID: 34324180
-
Direct Neural Reprogramming in situ: Existing Approaches and Their Optimization.Biochemistry (Mosc). 2025 Feb;90(2):214-230. doi: 10.1134/S000629792460426X. Biochemistry (Mosc). 2025. PMID: 40254400 Review.
-
Chemically Induced Reprogramming of Somatic Cells to Pluripotent Stem Cells and Neural Cells.Int J Mol Sci. 2016 Feb 6;17(2):226. doi: 10.3390/ijms17020226. Int J Mol Sci. 2016. PMID: 26861316 Free PMC article. Review.
Cited by
-
In Vivo Reprogramming Using Yamanaka Factors in the CNS: A Scoping Review.Cells. 2024 Feb 15;13(4):343. doi: 10.3390/cells13040343. Cells. 2024. PMID: 38391956 Free PMC article.
-
Building on a Solid Foundation: Adding Relevance and Reproducibility to Neurological Modeling Using Human Pluripotent Stem Cells.Front Cell Neurosci. 2021 Nov 18;15:767457. doi: 10.3389/fncel.2021.767457. eCollection 2021. Front Cell Neurosci. 2021. PMID: 34867204 Free PMC article.
-
Induced Neurons for Disease Modeling and Repair: A Focus on Non-fibroblastic Cell Sources in Direct Reprogramming.Front Bioeng Biotechnol. 2021 Mar 12;9:658498. doi: 10.3389/fbioe.2021.658498. eCollection 2021. Front Bioeng Biotechnol. 2021. PMID: 33777923 Free PMC article. Review.
-
Somatic Cell Reprogramming for Nervous System Diseases: Techniques, Mechanisms, Potential Applications, and Challenges.Brain Sci. 2023 Mar 22;13(3):524. doi: 10.3390/brainsci13030524. Brain Sci. 2023. PMID: 36979334 Free PMC article. Review.
-
Integrase deficient lentiviral vector: prospects for safe clinical applications.PeerJ. 2022 Aug 12;10:e13704. doi: 10.7717/peerj.13704. eCollection 2022. PeerJ. 2022. PMID: 35979475 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources